Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Chemours (CC) Operating Expenses (2016 - 2025)

Chemours (CC) has 12 years of Operating Expenses data on record, last reported at $161.0 million in Q4 2025.

  • For Q4 2025, Operating Expenses fell 21.08% year-over-year to $161.0 million; the TTM value through Dec 2025 reached $979.0 million, up 18.96%, while the annual FY2025 figure was $966.0 million, 17.38% up from the prior year.
  • Operating Expenses reached $161.0 million in Q4 2025 per CC's latest filing, up from $152.0 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $806.0 million in Q2 2023 and bottomed at $152.0 million in Q3 2025.
  • Average Operating Expenses over 5 years is $245.0 million, with a median of $186.0 million recorded in 2021.
  • Peak YoY movement for Operating Expenses: surged 187.86% in 2023, then plummeted 77.3% in 2024.
  • A 5-year view of Operating Expenses shows it stood at $189.0 million in 2021, then increased by 11.64% to $211.0 million in 2022, then increased by 21.8% to $257.0 million in 2023, then fell by 20.62% to $204.0 million in 2024, then decreased by 21.08% to $161.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Expenses were $161.0 million in Q4 2025, $152.0 million in Q3 2025, and $483.0 million in Q2 2025.